Watch the recording with Alexion Pharmaceuticals to learn about the Flex Study to evaluate the safety and efficacy of...
Dermatomyositis (DM) is a rare, autoimmune muscle and skin disease that can also affect the heart, lungs, and other organs of the body.
DM is one of several types of the Idiopathic Inflammatory Myopathies. The term “idiopathic” means no known cause.
Understanding the Dermatomyositis Journey & Experience

Seeking ten (10) people living with Dermatomyositis who would be willing to share their personal experience in a market...
Myositis Support & Understanding and AllStripes Partner for New Dermatomyositis Research

Myositis Support & Understanding and AllStripes are partnering to create a database that will enable new Dermatomyositis research projects!...
Corbus Pharmaceuticals Announces Topline Results from DETERMINE Phase 3 Study of Lenabasum for Treatment of Dermatomyositis

Corbus releases topline results for the phase 3 study of lenabasum in dermatomyositis. While it didn't meet the primary...
A Closer Look: Clinical Trials and the PRESIDIO Study

Clinical trials are a key research tool for advancing medical knowledge and patient care. Join Kezar Life Sciences as...
Skin findings seen with myositis autoantibodies and treatment of skin in dermatomyositis

Dr. Victoria Werth joined us live online for a video education session titled, "Skin findings seen with myositis autoantibodies...
DETERMINE - a Phase 3 trial designed to evaluate the efficacy and safety of lenabasum for the treatment of adults...
Corbus launches DETERMINE, a Phase 3 trial of lenabasum for the treatment of dermatomyositis

New locations announced July 9, 2019. DETERMINE is a double-blind, placebo-controlled 1-year study designed to test the efficacy and...
Myositis and Cancer: Risk highest for carriers of anti-TIF1 antibody

The research found that DM patients with the anti-transcriptional intermediary factor 1 (anti-TIF1) antibody were more than three times...
"New Developments on the Role of Itch in Dermatomyositis", based on new research published in the British Journal of...
Dr. Victoria Werth, MD, presents, "Overview and new developments in Dermatomyositis." This was a live Myositis Support and Understanding...
Chronic Illness, Myositis, and Depression: The following are the comments I gave to a support group about my book,...
Did you know there are doctors who have combined training in both Dermatology and Rheumatology? These physicians are referred...
Dermatomyositis is a rare autoimmune disease, occurring in only 5-10 people per million, which is caused by the body’s...
Helpful Resources
Myositis News
-
Pain profile and opioid medication use in patients with idiopathic inflammatory myopathies May 19, 2022
-
Clinical Study in Dermatomyositis May 18, 2022
-
Myositis Journey and Burden of Disease Study May 2, 2022
-
Dr. Abhiram Bhashyam joins MSU as Research Partner April 21, 2022
-
Intravenous Immune Globulin (IVIg) – A newly approved therapeutic option for the treatment of adult dermatomyositis April 5, 2022